Are SARMs legal in Sweden in 2026? Legal status and what the law says
01 Mar
The question of whether SARMs are legal in Sweden comes up in almost every forum thread, comment field and DM conversation that touches on the subject. The answer is not a simple yes or no — the legal status of SARMs in Sweden is in a gray area that depends on the specific substance involved, how it acts in the body and which legislation is applied. We go through the doping law, the Swedish Medicines Agency’s assessments, the Customs Agency’s practice and what it actually means in practice if you are considering buying SARMs in Sweden in 2026.
The doping law — the basis for all assessment
The Swedish Doping Act (1991:1969) is the primary regulatory framework that governs which substances are prohibited to possess, use, import and sell. The law regulates four categories of doping agents: synthetic anabolic steroids, testosterone including derivatives, growth hormone and chemical substances that increase the production or release of testosterone and its derivatives or of growth hormone.
The last category — “chemical substances that increase the production or release of testosterone and its derivatives or of growth hormone” — is deliberately worded broadly, and this is where the legal gray area for SARMs arises. The law does not contain an exhaustive list of prohibited substances in the way that the Narcotics Penal Code does. Instead, the assessment is made based on the substance’s pharmacological action mechanism.
This means that each individual SARM must be assessed individually. A substance that directly increases testosterone production or release may fall under the doping law, while a substance that acts via a completely different mechanism — for example the PPARδ receptor or the ghrelin receptor — may fall outside the scope of the law.
SARMs substance by substance — where is the line?
As “SARMs” is a collective name for a heterogeneous group of substances with different mechanisms of action, the legal assessment is not the same for all. Here is a review of the most common substances and their likely legal status.
Ostarine (MK-2866) is a selective androgen receptor modulator in the true sense of the word. It binds directly to the androgen receptor and activates it selectively in muscle and bone tissue. Ostarine suppresses the body’s own testosterone production at typical doses, which indicates a hormone influencing effect. The Swedish Medicines Agency has not published an explicit assessment of Ostarine, but the substance’s mechanism of action means that it can probably be assessed as doping if it were interpreted strictly under the doping law.
RAD-140 (Testolone) has a clearer status. The Swedish Medicines Agency has expressly assessed RAD-140 as a medicine, which means that it may not be imported for personal use via online purchase. The substance is a potent androgen receptor agonist that strongly suppresses testosterone at pharmacological doses. RAD-140 is closer to the doping-rated spectrum than most other SARMs.
Ligandrol (LGD-4033) works on the same principle as Ostarine — selective androgen receptor binding — but with higher potency. Studies show that LGD-4033 significantly lowers free testosterone and SHBG, which suggests that the substance falls under the Doping Act’s formulation of chemical substances that affect testosterone levels. In practice, Ligandrol is treated in the same gray area as Ostarine, but with a stronger connection to doping legislation.
MK-677 (Ibutamoren) is technically not a SARM but a ghrelin-mimetic growth hormone releaser. It activates the ghrelin receptor and increases the production of growth hormone. Since the doping law explicitly mentions “chemical substances that increase the production or release of growth hormone”, MK-677 most likely falls directly under the law’s scope of application. That paradoxically makes it more legally exposed than several actual SARMs.
Cardarine (GW501516) is a PPARδ receptor agonist that does not affect the androgen receptor, testosterone or growth hormone. It probably does not fall under the doping law, but can potentially be assessed as a drug by the Swedish Medicines Agency based on its pharmacological effects. Cardarine is in the most obscure gray area of all.
SR-9009 (Stenabolic) is a Rev-Erbα agonist that affects circadian rhythm and metabolism without connection to the androgen receptor or the hormonal system. Like Cardarine, it probably falls outside the doping law’s direct scope of application, but can be assessed as a medicine.
The role of the Swedish Medicines Agency — when substances are classified as medicines
Parallel to the doping law is the pharmaceutical legislation. The Swedish Medicines Agency assesses individual substances and decides whether they should be classified as medicines. A substance classified as a drug may not be imported for personal use via online shopping — regardless of whether it is classified as doping or not.
The Swedish Medicines Agency has confirmed that most SARMs “should generally be regarded as medicinal products” based on their pharmacological properties. Specifically, the authority has made an explicit assessment that RAD-140 (Testolone) is classified as a drug. For other SARMs there is no published individual assessment, but the authority’s general stance is that substances with documented pharmacological activity on the hormonal system are typically assessed as medicines.
This means in practice that even if a specific SARM does not fall under the Doping Act, it may still be illegal to import if it is deemed to be a drug. The double connection between the doping law and the drug law creates a legal net that captures most substances in the SARMs category.
Customs and practical handling
Customs has the authority to confiscate substances deemed to be doping agents or illegal drugs upon importation. In practice, this means that packages containing SARMs can be stopped at the border, regardless of the exact legal status of the substance.
Customs officers make an initial assessment on the spot, often based on labelling, substance names and packaging. If the assessment is unclear, the substance is forwarded to the Medical Products Agency or the Public Health Agency for analysis. The process can take weeks or months, and in the meantime the shipment is seized.
It is worth being realistic: Customs’ knowledge of individual SARMs varies. A substance that technically may not fall under the Anti-Doping Act can still be seized if the official judges that it looks like a doping agent or drug. In practice, the burden of proof falls on the recipient, who must demonstrate that the substance is not prohibited.
WADA and organized sport
In organized sports, the picture is clear. WADA (World Anti-Doping Agency) bans all SARMs, MK-677, Cardarine and SR-9009 under the categories of “anabolic agents” and “hormone and metabolic modulators” respectively. The list is updated annually and applies regardless of national legislation.
Antidoping Sweden fully applies WADA’s doping list. Competitive athletes who test positive for any of these substances risk suspension, revoked licensing and disclosure. Detection times vary — some SARMs can be detected in urine for several weeks after last ingestion.
If you play any type of organized sport with doping controls — at any level — all substances discussed in this article are strictly prohibited. No exceptions.
Summary — Legal Reality 2026
The practical reality of SARMs in Sweden in 2026 is a gray area, but a gray area that leans on the restrictive side. Most SARMs with androgen receptor activity (Ostarine, RAD-140, Ligandrol, YK-11) risk falling under the Doping Act, the Medicines Act or both. MK-677 probably falls directly under the anti-doping law. Cardarine and SR-9009 have the strongest arguments for being outside the doping law, but can still be assessed as drugs.
None of this constitutes legal advice — it is a summary of current legislation and government practice. Anyone who wants a concrete answer about a specific substance should contact the Swedish Medicines Agency or a lawyer with expertise in drug and doping law. A review of SARM’s effects and properties can provide additional context to understand why these substances have ended up in regulatory focus.
.entry-content